Provectus Biopharmaceuticals, Inc. (PVCT) — 10-K/A Filings
All 10-K/A filings from Provectus Biopharmaceuticals, Inc.. Browse 2 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (2)
-
Provectus Biopharma Files 2024 Annual Report Amendment
— May 16, 2025 Risk: medium
Provectus Biopharmaceuticals, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, submitted on May 16 -
Provectus Biopharmaceuticals Files 10-K/A Amendment
— Apr 29, 2024 Risk:
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) filed a Amended Annual Report (10-K/A) with the SEC on April 29, 2024. Provectus Biopharmaceuticals, Inc. filed an ame
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX